Protective Effect of Probiotics Isolated from Traditional Fermented Tea Leaves (Miang) from Northern Thailand and Role of Synbiotics in Ameliorating Experimental Ulcerative Colitis in Mice.
Napapan KangwanSarawut KongkarnkaNitsara BoonkerdKridsada UnbanKalidas ShettyChartchai KhanongnuchaPublished in: Nutrients (2022)
This study aimed to investigate the protective effect of probiotics and synbiotics from traditional Thai fermented tea leaves (Miang) on dextran sulfate sodium (DSS)-induced colitis in mice, in comparison to sulfasalazine. C57BL/6 mice were treated with probiotics L. pentosus A14-6, CMY46 and synbiotics, L. pentosus A14-6 combined with XOS, and L. pentosus CMY46 combined with GOS for 21 days. Colitis was induced with 2% DSS administration for seven days during the last seven days of the experimental period. The positive group was treated with sulfasalazine. At the end of the experiment, clinical symptoms, pathohistological changes, intestinal barrier integrity, and inflammatory markers were analyzed. The probiotics and synbiotics from Miang ameliorated DSS-induced colitis by protecting body weight loss, decreasing disease activity index, restoring the colon length, and reducing pathohistological damages. Furthermore, treatment with probiotics and synbiotics improved intestinal barrier integrity, accompanied by lowing colonic and systemic inflammation. In addition, synbiotics CMY46 combined with GOS remarkedly elevated the expression of IL-10. These results suggested that synbiotics isolated from Miang had more effectiveness than sulfasalazine. Thereby, they could represent a novel potential natural agent against colonic inflammation.
Keyphrases
- ulcerative colitis
- disease activity
- rheumatoid arthritis
- systemic lupus erythematosus
- weight loss
- high fat diet induced
- randomized controlled trial
- systematic review
- oxidative stress
- ankylosing spondylitis
- poor prognosis
- juvenile idiopathic arthritis
- bariatric surgery
- rheumatoid arthritis patients
- type diabetes
- insulin resistance
- risk assessment
- roux en y gastric bypass
- binding protein
- climate change
- human health
- clinical evaluation